OSI Systems (OSIS) 10-Q 24 Oct 14 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Sep. 30, 2014	Oct. 23, 2014
Document and Entity Information	'	'
Entity Registrant Name	'OSI SYSTEMS INC	'
Entity Central Index Key	'0001039065	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--06-30	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	19,829,016
Document Fiscal Year Focus	'2015	'
Document Fiscal Period Focus	'Q1	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$37,274	$38,831
Accounts receivable, net	155,849	185,773
Inventories	264,394	234,138
Deferred taxes	73,362	73,510
Prepaid expenses and other current assets	52,122	46,978
Total current assets	583,001	579,230
Property and equipment, net	250,193	260,479
Goodwill	97,430	92,607
Intangible assets, net	47,628	43,615
Other assets	49,803	48,255
Total assets	1,028,055	1,024,186
Current liabilities:	'	'
Bank lines of credit	30,000	24,000
Current portion of long-term debt	2,820	2,819
Accounts payable	80,552	74,460
Accrued payroll and related expenses	29,481	32,997
Advances from customers	43,873	38,493
Deferred revenue	55,958	60,677
Income taxes payable	24,956	20,556
Other accrued expenses and current liabilities	53,994	55,977
Total current liabilities	321,634	309,979
Long-term debt	11,267	10,436
Advances from customers	43,750	50,000
Deferred income taxes	73,978	73,161
Other long-term liabilities	55,257	48,397
Total liabilities	505,886	491,973
Commitments and contingencies (Note 7)	'	'
Stockholders' equity:	'	'
Preferred stock, $0.001 par value - authorized, 10,000,000 shares; no shares issued or outstanding	'	'
Common stock, $0.001 par value - authorized, 100,000,000 shares; issued and outstanding, 19,942,923 shares at June 30, 2014 and 19,802,749 shares at September 30, 2014	268,713	287,434
Retained earnings	258,929	247,680
Accumulated other comprehensive loss	-5,473	-2,901
Total stockholders' equity	522,169	532,213
Total liabilities and stockholders' equity	$1,028,055	$1,024,186

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Jun. 30, 2014
CONDENSED CONSOLIDATED BALANCE SHEETS	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, authorized shares	100,000,000	100,000,000
Common stock, shares issued	19,802,749	19,942,923
Common stock, shares outstanding	19,802,749	19,942,923

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Net revenues:	'	'
Products	$156,488	$143,476
Services	61,909	62,798
Total net revenues	218,397	206,274
Cost of goods sold:	'	'
Products	107,424	103,593
Services	36,731	34,735
Total cost of goods sold	144,155	138,328
Gross profit	74,242	67,946
Operating expenses:	'	'
Selling, general and administrative	44,182	42,214
Research and development	12,670	11,020
Restructuring and other charges	726	4,239
Total operating expenses	57,578	57,473
Income from operations	16,664	10,473
Interest and other expense, net	-864	-1,470
Income before income taxes	15,800	9,003
Provision for income taxes	4,551	2,609
Net income	$11,249	$6,394
Net income per share:	'	'
Basic (in dollars per share)	$0.57	$0.32
Diluted (in dollars per share)	$0.55	$0.31
Shares used in per share calculation:	'	'
Basic (in shares)	19,820	19,971
Diluted (in shares)	20,529	20,620

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME	'	'
Net income	$11,249	$6,394
Other comprehensive income (loss):	'	'
Foreign currency translation adjustment	-2,698	1,308
Other	126	92
Other comprehensive income (loss)	-2,572	1,400
Comprehensive income	$8,677	$7,794

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net income	$11,249	$6,394
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	17,741	12,873
Stock based compensation expense	5,995	5,638
Other	69	193
Changes in operating assets and liabilities-net of business acquisitions:	'	'
Accounts receivable	30,159	6,305
Inventories	-29,381	-16,092
Accounts payable	2,933	-3,151
Accrued payroll and related expenses	-4,008	-2,308
Deferred revenue	-3,382	-3,145
Other	78	-460
Net cash provided by operating activities	31,453	6,247
Cash flows from investing activities:	'	'
Acquisition of property and equipment	-3,136	-7,971
Acquisition of businesses, net of cash acquired	-10,869	-9,302
Acquisition of intangible and other assets	-1,063	-1,756
Net cash used in investing activities	-15,068	-19,029
Cash flows from financing activities:	'	'
Net borrowings on bank lines of credit	6,000	20,000
Proceeds from long-term debt	516	2,769
Payments on long-term debt	-815	-805
Proceeds from exercise of stock options and employee stock purchase plan	209	1,501
Repurchase of common shares	-18,373	-1,514
Taxes paid related to net share settlement of equity awards	-6,552	-7,481
Net cash provided by (used in) financing activities	-19,015	14,470
Effect of exchange rate changes on cash	1,073	801
Net increase (decrease) in cash and cash equivalents	-1,557	2,489
Cash and cash equivalents-beginning of period	38,831	34,697
Cash and cash equivalents-end of period	37,274	37,186
Cash paid, net during the period for:	'	'
Interest	696	1,174
Income taxes	$1,735	$4,001

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Sep. 30, 2014
Basis of Presentation	'
Basis of Presentation	'
	1. Basis of Presentation
	Description of Business
	OSI Systems, Inc., together with its subsidiaries (the “Company”), is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. The Company sells its products and provides related services in diversified markets, including homeland security, healthcare, defense and aerospace.
	The Company has three reporting segments: (i) Security, providing security inspection systems, turnkey security screening solutions and related services; (ii) Healthcare, providing patient monitoring, cardiology and anesthesia systems, and related services and (iii) Optoelectronics and Manufacturing, providing specialized electronic components and electronic manufacturing services for the Security and Healthcare divisions as well as to external original equipment manufacturing clients for applications in the defense, aerospace, medical and industrial markets, among others.
	Through its Security division, the Company provides security screening, threat detection and non-intrusive inspection products and related services globally. These products fall into the following categories: baggage and parcel inspection systems; cargo and vehicle inspection systems; hold (checked) baggage screening systems; people screening; radiation detection; and trace detection. In addition to these products, the Company provides site design, installation, training and technical support services to its customers. The Company also provides turnkey security screening solutions, which can include the construction, staffing and long-term operation of security screening checkpoints for its customers.
	Through its Healthcare division, the Company designs, manufactures, markets and services patient monitoring, cardiology and anesthesia delivery and ventilation systems, and related supplies and accessories worldwide. These products are used by care providers in critical care, emergency and perioperative areas within hospitals as well as physicians’ offices, medical clinics and ambulatory surgery centers amongst others.
	Through its Optoelectronics and Manufacturing division, the Company designs, manufactures and markets optoelectronic devices and provides electronics manufacturing services worldwide for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostic products, telecommunications, computer peripherals, industrial automation systems, automotive diagnostic systems, gaming systems and consumer products. This division provides products and services to original equipment manufacturers and end users as well as to the Company’s own Security and Healthcare divisions.
	Basis of Presentation
	The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by the Company, without audit, pursuant to interim financial reporting guidelines. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company’s management, the condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented. These condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014. The results of operations for the three months ended September 30, 2014 are not necessarily indicative of the operating results to be expected for the full 2015 fiscal year or any future periods.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and costs of sales during the reporting period. The most significant of these estimates and assumptions for the Company relate to contract revenue, profit and loss recognition, fair values of assets acquired and liabilities assumed in business combinations, market values for inventories reported at lower of cost or market, stock-based employee compensation expense, income taxes, accrued product warranty costs, and the recoverability, useful lives and valuation of recorded amounts of long-lived assets, identifiable intangible assets and goodwill. Changes in estimates are reflected in the periods during which they become known. Actual amounts will differ from these estimates and could differ materially.
	Per Share Computations
	The Company computes basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. The Company computes diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common and dilutive potential common shares outstanding. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock awards or units under the treasury stock method.  Stock awards to purchase 0.1 million shares of common stock for the three months ended September 30, 2014 were excluded from the calculation of diluted earnings per share because to do so would have been antidilutive, while during the three months ended September 30, 2013 no stock awards were excluded from the calculation.
	The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
		Three Months Ended
		September 30,
		2013		2014
	Net income for diluted earnings per share calculation	$	6,394	$	11,249
	Weighted average shares for basic earnings per share calculation	19,971		19,820
	Dilutive effect of stock awards	649		709
	Weighted average shares for diluted earnings per share calculation	20,620		20,529
	Basic net income per share	$	0.32	$	0.57
	Diluted net income per share	$	0.31	$	0.55
	Reclassifications
	Certain reclassifications have been made to prior year amounts within the condensed consolidated balance sheet and condensed consolidated statement of cash flows to conform to the current year’s presentation.
	Cash Equivalents
	The Company considers all highly liquid investments purchased with maturities of approximately three months or less as of the acquisition date to be cash equivalents.
	Fair Value of Financial Instruments
	The Company’s financial instruments consist primarily of cash, marketable securities, derivative instruments, accounts receivable, accounts payable and debt instruments. The carrying values of financial instruments, other than long-term debt instruments, are representative of their fair values due to their short-term maturities. The carrying values of the Company’s long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates offered to the Company.
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. “Level 1” category includes assets and liabilities at the quoted prices in active markets for identical assets and liabilities.  “Level 2” category includes assets and liabilities from observable inputs other than quoted market prices. “Level 3” category includes assets and liabilities whose valuation techniques are unobservable and significant to the fair value measurement.  There were no assets or liabilities where “Level 3” valuation techniques were used, and there were no assets and liabilities measured at fair value on a non-recurring basis.
	The following is a summary of the investments carried at fair value (in thousands):
		Level 1		Level 2		June 30,		Level 1		Level 2		September 30,
						2014						2014
	Equity securities	414		500		914		385		1,600		1,985
	Insurance company contracts	—		17,383		17,383		—		18,077		18,077
	Interest rate contract	—		28		28		—		61		61
	Total	$	414	$	17,911	$	18,325	$	385	$	19,738	$	20,123
	Derivative Instruments and Hedging Activity
	The Company’s use of derivatives consists of an interest rate swap agreement.  The interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to variable, LIBOR-based debt for the duration of the term loan.  The interest rate swap matures in October 2019.  The interest rate swap is considered an effective cash flow hedge, and, as a result, the net gains or losses on such instrument were reported as a component of Other comprehensive income in the condensed consolidated financial statements and are reclassified as net income when the hedge transaction settles.
	Revenue Recognition
	The Company recognizes revenue from sales of products upon shipment when title and risk of loss passes, and when terms are fixed and collection is probable. Revenue from services includes after-market services, installation and implementation of products, and turnkey security screening services. The portion of revenue for the sale attributable to installation is deferred and recognized when the installation service is provided. In an instance where terms of sale include subjective customer acceptance criteria, revenue is deferred until the Company has achieved the acceptance criteria. Concurrent with the shipment of the product, the Company accrues estimated product return reserves and warranty expenses. Critical judgments made by management related to revenue recognition include the determination of whether or not customer acceptance criteria are perfunctory or inconsequential. The determination of whether or not customer acceptance terms are perfunctory or inconsequential impacts the amount and timing of revenue recognized. Critical judgments also include estimates of warranty reserves, which are established based on historical experience and knowledge of the product under warranty.
	Revenue from turnkey services agreements is included in revenue from services. In certain agreements, revenue is recognized based upon proportional performance, measured by the actual number of hours incurred divided by the total estimated number of hours for the project. The impact of changes in the estimated hours to service the agreement is reflected in the period during which the change becomes known. Deferred revenue for such agreements arises when payments from customers are received in advance of revenue recognition.
	Revenues from out of warranty service maintenance contracts are recognized ratably over the term of such contract. For services not derived from specific maintenance contracts, revenues are recognized as the services are performed. Deferred revenue for such services arises from payments received from customers for services not yet performed. On occasion, the Company receives advances from customers that are amortized against future customer payments pursuant to the underlying agreements. Such advances are classified in the condensed consolidated balance sheets as either a current or long term liability dependent upon when the Company estimates the corresponding amortization to occur.
	Business Combinations
	During the normal course of business the Company makes acquisitions.  In the event that an individual acquisition (or an aggregate of acquisitions) is material, appropriate disclosure of such acquisition activity is provided.  During the three months ended September 30, 2014, the Company completed an acquisition that was not material.
	Recent Accounting Updates Not Yet Adopted
	In May 2014, the Financial Accounting Standards Board issued an accounting standards update amending revenue recognition requirements for multiple deliverable revenue arrangements. This update provides guidance on how revenue is recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for the goods or services. This determination is made in five steps: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The update is effective for annual reporting periods after December 15, 2016 and for interim reporting periods within that reporting period. Early adoption is not permitted. The Company has not yet adopted this update and is currently evaluating the impact it may have on its financial condition and results of operations.

Balance_Sheet_Details

Balance Sheet Details	3 Months Ended
	Sep. 30, 2014
Balance Sheet Details	'
Balance Sheet Details	'
	2. Balance Sheet Details
	The following tables provide details of selected balance sheet accounts (in thousands):
		June 30,			September 30,
		2014			2014
	Accounts receivable
	Billed receivables	$	189,489		$	160,202
	Unbilled receivables	1,975			2,552
	Less allowance for doubtful accounts	(5,691		)	(6,905		)
	Total	$	185,773		$	155,849
		June 30,			September 30,
		2014			2014
	Inventories
	Raw materials	$	117,945		$	146,525
	Work-in-process	33,394			44,743
	Finished goods	82,799			73,126
	Total	$	234,138		$	264,394
		June 30,			September 30,
		2014			2014
	Property and equipment, net
	Land	$	13,651		$	13,651
	Buildings and improvements	163,952			166,468
	Leasehold improvements	9,744			10,058
	Equipment and tooling	154,367			154,501
	Furniture and fixtures	4,017			4,052
	Computer equipment	17,466			17,810
	Computer software	15,670			15,968
	Construction in process	12,650			10,612
	Total	391,517			393,120
	Less: accumulated depreciation and amortization	(131,038		)	(142,927		)
	Property and equipment, net	$	260,479		$	250,193
	During the three months ended September 30, 2013 and 2014, depreciation expense was approximately $11.5 million and $16.9 million, respectively.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	3 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets	'
Goodwill and Intangible Assets	'
	3. Goodwill and Intangible Assets
	The changes in the carrying value of goodwill for the three-month period ended September 30, 2014 are as follows (in thousands):
		Security			Healthcare			Optoelectronics			Consolidated
		Division			Division			and
								Manufacturing
								Division
	Balance as of June 30, 2014	$	29,507		$	37,237		$	25,863		$	92,607
	Goodwill acquired or adjusted during the period	19			5,655			37			5,711
	Foreign currency translation adjustment	(281		)	(283		)	(324		)	(888		)
	Balance as of September 30, 2014	$	29,245		$	42,609		$	25,576		$	97,430
	Intangible assets consisted of the following (in thousands):
				June 30, 2014									September 30, 2014
		Weighted		Gross			Accumulated			Intangibles			Gross		Accumulated		Intangibles
		Average		Carrying			Amortization			Net			Carrying		Amortization		Net
		Lives		Value									Value
	Amortizable assets:
	Software development costs	9 years		$	21,165		6,716			14,449			$	21,275	$	6,855	$	14,420
	Patents	20 years		6,566			765			5,801			6,814		804		6,010
	Core technology	10 years		2,289			2,150			139			2,187		2,109		78
	Developed technology	10 years		18,308			11,559			6,749			20,369		11,853		8,516
	Customer relationships/backlog	7 years		11,419			7,011			4,408			10,070		4,032		6,038
	Total amortizable assets			59,747			28,201			31,546			60,715		25,653		35,062
	Non-amortizable assets:
	Trademarks			12,069			—			12,069			12,566		—		12,566
	Total intangible assets			$	71,816		$	28,201		$	43,615		$	73,281	$	25,653	$	47,628
	Amortization expense related to intangibles assets was $1.4 million and $0.8 million for the three months ended September 30, 2013 and 2014, respectively. At September 30, 2014, the estimated future amortization expense was as follows (in thousands):
	Fiscal Years
	2015 (remaining 9 months)	$	2,994
	2016	3,757
	2017	3,913
	2018	3,826
	2019	3,582
	2020	3,116
	2021 and thereafter, including assets that have not yet begun to be amortized	13,874
	Total	$	35,062
	Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product by product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio that current revenues for a product bear to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in thereafter in the table above. During the three months ended September 30, 2013 and 2014, the Company capitalized software development costs in the amount of $1.2 million and $0.6 million, respectively.

Borrowings

Borrowings	3 Months Ended
	Sep. 30, 2014
Borrowings	'
Borrowings	'
	4. Borrowings
	The Company has a $450 million credit agreement maturing in May 2019. The credit agreement consists of a $450 million revolving credit facility, including a $375 million sub-limit for letters of credit. The Company has the ability to increase the facility by $200 million under certain circumstances. Borrowings under this facility bear interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 1.25% as of September 30, 2014. This margin is determined by the Company’s consolidated leverage ratio and may range from 1.25% to 2.0%. Letters of credit reduce the amount available to borrow by their face value. As of September 30, 2014, the unused portion of the facility bears a commitment fee of 0.20%, but can range from 0.20% to 0.35% based on the Company’s consolidated leverage ratio. The Company’s borrowings under the credit agreement are guaranteed by the Company’s U.S.-based subsidiaries and are secured by substantially all of the Company’s and certain subsidiaries’ assets. The agreement contains various representations, warranties, affirmative, negative and financial covenants, and conditions of default customary for financing agreements of this type. As of September 30, 2014, there was $30.0 million outstanding under the revolving credit facility and $100.1 million outstanding under the letters-of-credit sub-facility.
	Several of the Company’s foreign subsidiaries maintain bank lines-of- credit, denominated in local currencies and US dollars, to meet short-term working capital requirements and for the issuance of letters-of-credit. As of September 30, 2014, $11.6 million was outstanding under these letter-of-credit facilities, while no debt was outstanding. As of September 30, 2014, the total amount available under these credit facilities was $26.4 million, with a total cash borrowing sub-limit of $2.9 million.
	In September 2012, the Company entered into a term loan agreement for $11.1 million to fund the acquisition of land and a building in the state of Washington.  The loan, which bears interest at LIBOR plus 1.25%, is payable on a monthly basis over seven years.  Concurrent with entering into the floating rate loan, the Company entered into an interest rate swap agreement that effectively locks the interest rate of the loan to 2.2% per annum for the term of the loan.
	Long-term debt consisted of the following (in thousands):
		June 30,		September 30,
		2014		2014
	Term loans	$	10,921	$	11,607
	Other long-term debt	2,334		2,480
		13,255		14,087
	Less current portion of long-term debt	2,819		2,820
	Long-term portion of debt	$	10,436	$	11,267

Stockbased_Compensation

Stock-based Compensation	3 Months Ended
	Sep. 30, 2014
Stock-based Compensation	'
Stock-based Compensation	'
	5. Stock-based Compensation
	As of September 30, 2014, the Company maintained two share-based employee compensation plans (the “OSI Plans”): the 2012 Incentive Award Plan (“2012 Plan”) and the Amended and Restated 2006 Equity Participation Plan (“2006 Plan”). Upon stockholder approval of the 2012 Plan, the Company ceased to make grants under the 2006 Plan.
	The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):
		Three Months Ended
		September 30,
		2013			2014
	Cost of goods sold	$	269		$	205
	Selling, general and administrative	5,303			5,763
	Research and development	66			27
	Stock-based compensation expense before taxes	$	5,638		$	5,995
	Less: related income tax benefit	2,174			2,406
	Stock-based compensation expense, net of estimated taxes	$	3,464		$	3,589
	As of September 30, 2014, total unrecognized compensation cost related to share-based compensation grants were estimated at $1.4 million for stock options and $30.5 million for restricted stock and restricted stock units (“RSUs”) under the OSI Plans.  The Company expects to recognize these costs over a weighted-average period of 2.2 years with respect to the options and 1.9 years for grants of restricted stock and RSUs.
	The following summarizes stock option activity during the three months ended September 30, 2014:
		Number of		Weighted-			Weighted-Average	Aggregate
		Options		Average Exercise			Remaining	Intrinsic Value
				Price			Contractual Term	(in thousands)
	Outstanding at June 30, 2014	1,022,991		$	26.6
	Granted	42,476		$	68.03
	Exercised	(4,154	)	$	50.27
	Expired or forfeited	(2,623	)	$	56.94
	Outstanding at September 30, 2014	1,058,690		$	28.09		5.6 years	$	36,839
	Exercisable at September 30, 2014	949,969		$	24.35		5.2 years	$	36,297
	A summary of restricted stock and RSU award activity during the three months ended September 30, 2014 is as follows:
		Shares		Weighted-
				Average
				Fair Value
	Nonvested at June 30, 2014	661,400		$	54.78
	Granted	277,536		64.63
	Vested	(233,945	)	42.2
	Forfeited	(6,821	)	37.39
	Nonvested at September 30, 2014	698,170		63.08
	As of September 30, 2014, there were 2,973,477 shares available for grant under the 2012 Plan.  Under the terms of that plan, restricted stock and RSUs granted from the pool of shares available for grant on or after December 12, 2012 reduce the pool by 1.87 shares for each share granted.  Restricted stock and RSUs forfeited and returned to the pool of shares available for grant increase the pool by 1.87 shares for each share forfeited.
	The Company granted 160,922 and 151,469 performance-based units during the three months ended September 30, 2013 and 2014, respectively. These performance-based restricted stock awards are contingent on the achievement of certain financial performance metrics. The payout can range from zero to 250% of the original number of shares or units awarded, which are converted into shares of the Company’s common stock.

Retirement_Benefit_Plans

Retirement Benefit Plans	3 Months Ended
	Sep. 30, 2014
Retirement Benefit Plans	'
Retirement Benefit Plans	'
	6. Retirement Benefit Plans
	The Company sponsors various retirement benefit plans including qualified and nonqualified defined benefit pension plans for its employees. The components of net periodic pension expense are as follows (in thousands):
		Three Months Ended
		September 30,
		2013		2014
	Service cost	$	293	$	264
	Amortization of prior service cost	202		202
	Net periodic pension expense	$	495	$	466
	For the three months ended September 30, 2013 and 2014, the Company made contributions of $0.1 million and $1.0 million, respectively, to these defined benefit plans.
	In addition, the Company maintains various defined contribution plans. For the three months ended September 30, 2013 and 2014, the Company made contributions of $1.0 million and $1.2 million, respectively, to these defined contribution plans.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Sep. 30, 2014
Commitments and Contingencies	'
Commitments and Contingencies	'
	7. Commitments and Contingencies
	Contingent Acquisition Obligations
	Under the terms and conditions of the purchase agreements associated with certain acquisitions, the Company may be obligated to make additional payments based on the achievement by the acquired operations of certain sales or profitability milestones. The maximum amount of such future payments under arrangements with contingent consideration caps is $58 million as of September 30, 2014. In addition, one of the purchase agreements the Company entered into requires royalty payments through 2022 based on the license of, or sales of products containing the technology of CXR Limited, a company acquired in 2004. For acquisitions that occurred prior to fiscal year 2010, the Company accounts for such contingent payments as an addition to the purchase price of the acquired business. Otherwise, the estimated fair value of these obligations is recorded as a liability at the time of the acquisition in the condensed consolidated balance sheets with subsequent revisions reflected in the condensed consolidated statements of operations. As of June 30, 2014 and September 30, 2014, $23.2 million and $24.4 million of contingent payment obligations, respectively, are included in Other long-term liabilities in the accompanying condensed consolidated balance sheets.
	Advances from Customers
	The Company receives advances from customers associated with certain projects.  In fiscal 2012, the Company entered into an agreement with the Mexican government to provide a turnkey security screening solution along the country’s borders, and in its ports and airports.  Associated with the agreement, the Company was provided an advance totaling $100 million.  The Company is obligated to provide a guarantee until the advance has been fully amortized in fiscal 2017.  As of September 30, 2014, $68.8 million of this advance remains outstanding.
	Environmental Contingencies
	The Company is subject to various environmental laws. The Company’s practice is to conduct appropriate environmental investigations at its manufacturing facilities in North America, Asia Pacific, and Europe, and, to the extent practicable, on all new properties in order to identify, as of the date of such report, potential areas of environmental concern related to past and present activities or from nearby operations. In certain cases, the Company has conducted further environmental assessments consisting of soil and groundwater testing and other investigations deemed appropriate by independent environmental consultants.
	During one investigation at the Company’s Hawthorne, California facility, the Company discovered soil and groundwater contamination that it believes was the result of unspecified on- and off-site releases occurring prior to the Company’s occupancy. Historical usage of this site includes semiconductor and electronics manufacturing, dating back to the mid-1960s, as well as possible aircraft and related manufacturing dating to the early 1940s. Similar operations, including chemical manufacturing and storage, were conducted at neighboring sites throughout that period and into the 1990s. It is not presently known when the releases occurred or by whom they were caused, though Company records, in conjunction with data obtained from soil and groundwater surveys, support the Company’s assertion that these releases are historical in nature. Further, the groundwater contamination is a known regional issue, not limited to the Company’s premises or its immediate surroundings. The Company filed the requisite reports concerning this site with the appropriate environmental authorities upon discovery, and in cooperation with the local governing agency has provided additional historical information and conducted further site characterization studies. Recent soil and groundwater investigations, including the installation of groundwater monitoring wells, were completed in fiscal 2014. Results from these studies are being evaluated to determine the extent of the on-site releases and whether any soils remediation will be required. Periodic groundwater monitoring is expected to continue until such time as the governing authority requests further action.
	The Company has not accrued for loss contingencies relating to the Hawthorne facility or any other environmental matters because it believes that, although unfavorable outcomes may be possible, they are not considered by the Company’s management to be probable and reasonably estimable. If one or more of environmental matters are resolved in a manner adverse to the Company, the impact on the Company’s business, financial condition, results of operations, financial position and/or liquidity could be material.
	Indemnifications
	In the normal course of business, the Company has agreed to indemnify certain parties with respect to certain matters. The Company has agreed to hold certain parties harmless against losses arising from a breach of representations, warranties or covenants, or out of intellectual property infringement or other claims made by third parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers. It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. The Company has not recorded any liability for costs related to indemnification as of September 30, 2014.
	Product Warranties
	The Company offers its customers warranties on many of the products that it sells. These warranties typically provide for repairs and maintenance of the products if problems arise during a specified time period after original shipment. Concurrent with the sale of products, the Company records a provision for estimated warranty expenses with a corresponding increase in cost of goods sold. The Company periodically adjusts this provision based on historical experience and anticipated expenses. The Company charges actual expenses of repairs under warranty, including parts and labor, to this provision when incurred.
	The following table presents changes in warranty provisions (in thousands):
		Three Months Ended
		September 30,
		2013			2014
	Balance at beginning of period	$	12,890		$	11,923
	Additions and adjustments	1,254			847
	Reductions for warranty repair costs	(785		)	(870		)
	Balance at end of period	$	13,359		$	11,900
	Legal Proceedings
	On December 12, 2013, a putative class action complaint was filed against the Company and certain of its officers in the United States District Court for the Central District of California (“Court”) captioned Roberti v. OSI Systems, Inc., et al., Case No. 2:13-cv-09174-MWF-VBK (the “Securities Class Action”). The Amended Complaint, filed on May 20, 2014, alleges that the Company and the individual defendants violated the Securities Exchange Act of 1934 by misrepresenting or failing to disclose facts concerning the status of Rapiscan’s efforts to develop Automated Threat Recognition software and the alleged use of unapproved parts in its baggage scanning systems in violation of its contract with the U.S. Transportation Security Administration (TSA). The Amended Complaint also asserts that the individual defendants allegedly sold stock based on material non-public information. Plaintiff demands a jury trial and seeks class certification, unspecified damages, an award of pre-judgment and post-judgment interest, attorneys’ and experts’ fees, costs, and other unspecified relief. On July 18, 2014, the Company filed a Motion to Dismiss the Amended Complaint. The Motion is scheduled to be heard on November 3, 2014.
	On April 15, 2014, a shareholder derivative complaint was filed in the Court purportedly on behalf of the Company against the members of the Company’s Board of Directors (as individual defendants), captioned Hagan v. Chopra, et al., Case No. 2:14-cv-02910-ODW-PJW (the “Derivative Action”). The complaint generally asserts the same factual allegations as those at issue in the related Securities Class Action and purports to allege claims for breach of fiduciary duties and unjust enrichment against the individual defendants on behalf of the Company. The complaint seeks unspecified damages, restitution, injunctive relief, attorneys’ and experts’ fees, costs, expenses, and other unspecified relief. The Derivative Action is currently stayed pending the resolution of the Motion to Dismiss in the Securities Class Action.
	While the Company believes that the Securities Class Action and the Derivative Action are without merit and intends to defend the litigation vigorously, it expects to incur costs associated with defending the Securities Class Action and the Derivative Action. At this early stage of litigation, the ultimate outcomes of the Securities Class Action and the Derivative Action are uncertain and the Company cannot reasonably predict the timing or outcomes, or estimate the amount of loss, if any, or their effect, if any, on its financial statements.
	The Company is involved in various other claims and legal proceedings arising in the ordinary course of business. In the Company’s opinion after consultation with legal counsel, the ultimate disposition of such proceedings is not likely to have a material adverse effect on its business, financial condition, results of operations or cash flows. The Company has not accrued for loss contingencies relating to such matters because the Company believes that, although unfavorable outcomes in the proceedings may be possible, they are not considered by management to be probable or reasonably estimable. If one or more of these matters are resolved in a manner adverse to the Company, the impact on the Company’s business, financial condition, results of operations and/or liquidity could be material.
	Other Matters
	On December 5, 2013, the Company’s Security division was notified by the TSA that a delivery order that it had received on September 26, 2013, for baggage and handling inspection systems was being terminated for default. The termination resulted from the use of an upgraded X-ray generator component. While the component had been vetted by the Security division’s internal quality assurance, the Security division had not met the contractual requirement of obtaining the TSA’s approval in advance. The upgraded X-ray generator component has since been approved for use by the TSA. The termination for default could result in a claim by the Government for compensation.  As of this date, no such claim has been made, and the Company does not know the likely amount of any such claim if it were to be made.  Also, as a result of this termination for default, the Security division was referred to the U.S. Department of Homeland Security (DHS) for further review. As a result of this review, in October 2014 the Security division entered into an Addendum to its Administrative Agreement dated June 21, 2013 with DHS.  Pursuant to the terms of the Addendum, the Security division has agreed, among other things, to extend the term of the Administrative Agreement by 24 months.

Income_Taxes

Income Taxes	3 Months Ended
	Sep. 30, 2014
Income Taxes	'
Income Taxes	'
	8. Income Taxes
	The provision for income taxes is determined using an effective tax rate that is subject to fluctuations during the year as new information is obtained.  The assumptions used to estimate the annual effective tax rate include factors such as the mix of pre-tax earnings in the various tax jurisdictions in which the Company operates, valuation allowances against deferred tax assets, increases or decreases in uncertain tax positions, utilization of research and development tax credits, changes in or the interpretation of tax laws in jurisdictions where the Company conducts business and certain tax elections. The Company recognizes deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of its assets and liabilities along with net operating loss and tax credit carryovers. The Company records a valuation allowance against its deferred tax assets to reduce the net carrying value to an amount that it believes is more likely than not to be realized. When the Company establishes or reduces the valuation allowance against its deferred tax assets, the provision for income taxes will increase or decrease, respectively, in the period such determination is made.

Segment_Information

Segment Information	3 Months Ended
	Sep. 30, 2014
Segment Information	'
Segment Information	'
	9. Segment Information
	The Company has determined that it operates in three identifiable industry segments: (a) security and inspection systems (Security division), (b) medical monitoring and anesthesia systems (Healthcare division) and (c) optoelectronic devices and manufacturing (Optoelectronics and Manufacturing division). The Company also has a corporate segment (Corporate) that includes executive compensation and certain other general and administrative expenses, expenses related to stock issuances and legal and audit and other professional service fees not allocated to product segments. Both the Security and Healthcare divisions comprise primarily end-user businesses, while the Optoelectronics and Manufacturing division primarily supplies components and subsystems to original equipment manufacturers, including to the Security and Healthcare divisions. Sales between divisions are at transfer prices that approximate market values.  All other accounting policies of the segments are the same as described in Note 1, Summary of Significant Accounting Policies of the Form 10-K for the fiscal year ended June 30, 2014.
	The following tables present the operations and identifiable assets by industry segment (in thousands):
		Three Months Ended
		September 30,
		2013			2014
	Revenues(2) — by Segment:
	Security division	$	97,153		$	113,439
	Healthcare division	45,787			47,834
	Optoelectronics and Manufacturing division, including intersegment revenues	71,311			69,086
	Intersegment revenues elimination	(7,977		)	(11,962		)
	Total	$	206,274		$	218,397
		Three Months Ended
		September 30,
		2013			2014
	Operating income (loss) — by Segment:
	Security division	$	11,622		17,259
	Healthcare division	(1,998		)	62
	Optoelectronics and Manufacturing division	4,765			4,327
	Corporate	(4,045		)	(4,517		)
	Eliminations(1)	129			(467		)
	Total	$	10,473		$	16,664
		June 30,			September 30,
		2014			2014
	Assets — by Segment:
	Security division	$	535,306		$	525,293
	Healthcare division	190,612			203,284
	Optoelectronics and Manufacturing division	169,084			165,407
	Corporate	133,836			139,189
	Eliminations(1)	(4,652		)	(5,118		)
	Total	$	1,024,186		$	1,028,055
	(1)    Eliminations within operating income primarily reflect the change in the elimination of intercompany profit in inventory not-yet-realized. Eliminations in assets reflect the amount of intercompany profits in inventory as of the balance sheet date. Such intercompany profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.
	(2)    One customer accounted for 15% of total net revenues for the three months ended September 30, 2013 and 2014.  One customer accounted for 10% of the net receivables as of September 30, 2014.

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	3 Months Ended
	Sep. 30, 2014
Basis of Presentation	'
Description of Business	'
	Description of Business
	OSI Systems, Inc., together with its subsidiaries (the “Company”), is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. The Company sells its products and provides related services in diversified markets, including homeland security, healthcare, defense and aerospace.
	The Company has three reporting segments: (i) Security, providing security inspection systems, turnkey security screening solutions and related services; (ii) Healthcare, providing patient monitoring, cardiology and anesthesia systems, and related services and (iii) Optoelectronics and Manufacturing, providing specialized electronic components and electronic manufacturing services for the Security and Healthcare divisions as well as to external original equipment manufacturing clients for applications in the defense, aerospace, medical and industrial markets, among others.
	Through its Security division, the Company provides security screening, threat detection and non-intrusive inspection products and related services globally. These products fall into the following categories: baggage and parcel inspection systems; cargo and vehicle inspection systems; hold (checked) baggage screening systems; people screening; radiation detection; and trace detection. In addition to these products, the Company provides site design, installation, training and technical support services to its customers. The Company also provides turnkey security screening solutions, which can include the construction, staffing and long-term operation of security screening checkpoints for its customers.
	Through its Healthcare division, the Company designs, manufactures, markets and services patient monitoring, cardiology and anesthesia delivery and ventilation systems, and related supplies and accessories worldwide. These products are used by care providers in critical care, emergency and perioperative areas within hospitals as well as physicians’ offices, medical clinics and ambulatory surgery centers amongst others.
	Through its Optoelectronics and Manufacturing division, the Company designs, manufactures and markets optoelectronic devices and provides electronics manufacturing services worldwide for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostic products, telecommunications, computer peripherals, industrial automation systems, automotive diagnostic systems, gaming systems and consumer products. This division provides products and services to original equipment manufacturers and end users as well as to the Company’s own Security and Healthcare divisions.
Basis of Presentation	'
	Basis of Presentation
	The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by the Company, without audit, pursuant to interim financial reporting guidelines. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company’s management, the condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented. These condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014. The results of operations for the three months ended September 30, 2014 are not necessarily indicative of the operating results to be expected for the full 2015 fiscal year or any future periods.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and costs of sales during the reporting period. The most significant of these estimates and assumptions for the Company relate to contract revenue, profit and loss recognition, fair values of assets acquired and liabilities assumed in business combinations, market values for inventories reported at lower of cost or market, stock-based employee compensation expense, income taxes, accrued product warranty costs, and the recoverability, useful lives and valuation of recorded amounts of long-lived assets, identifiable intangible assets and goodwill. Changes in estimates are reflected in the periods during which they become known. Actual amounts will differ from these estimates and could differ materially.
Per Share Computations	'
	Per Share Computations
	The Company computes basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. The Company computes diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common and dilutive potential common shares outstanding. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock awards or units under the treasury stock method.  Stock awards to purchase 0.1 million shares of common stock for the three months ended September 30, 2014 were excluded from the calculation of diluted earnings per share because to do so would have been antidilutive, while during the three months ended September 30, 2013 no stock awards were excluded from the calculation.
	The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
		Three Months Ended
		September 30,
		2013		2014
	Net income for diluted earnings per share calculation	$	6,394	$	11,249
	Weighted average shares for basic earnings per share calculation	19,971		19,820
	Dilutive effect of stock awards	649		709
	Weighted average shares for diluted earnings per share calculation	20,620		20,529
	Basic net income per share	$	0.32	$	0.57
	Diluted net income per share	$	0.31	$	0.55
Reclassifications	'
	Reclassifications
	Certain reclassifications have been made to prior year amounts within the condensed consolidated balance sheet and condensed consolidated statement of cash flows to conform to the current year’s presentation.
Cash Equivalents	'
	Cash Equivalents
	The Company considers all highly liquid investments purchased with maturities of approximately three months or less as of the acquisition date to be cash equivalents.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company’s financial instruments consist primarily of cash, marketable securities, derivative instruments, accounts receivable, accounts payable and debt instruments. The carrying values of financial instruments, other than long-term debt instruments, are representative of their fair values due to their short-term maturities. The carrying values of the Company’s long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates offered to the Company.
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. “Level 1” category includes assets and liabilities at the quoted prices in active markets for identical assets and liabilities.  “Level 2” category includes assets and liabilities from observable inputs other than quoted market prices. “Level 3” category includes assets and liabilities whose valuation techniques are unobservable and significant to the fair value measurement.  There were no assets or liabilities where “Level 3” valuation techniques were used, and there were no assets and liabilities measured at fair value on a non-recurring basis.
	The following is a summary of the investments carried at fair value (in thousands):
		Level 1		Level 2		June 30,		Level 1		Level 2		September 30,
						2014						2014
	Equity securities	414		500		914		385		1,600		1,985
	Insurance company contracts	—		17,383		17,383		—		18,077		18,077
	Interest rate contract	—		28		28		—		61		61
	Total	$	414	$	17,911	$	18,325	$	385	$	19,738	$	20,123
Derivative Instruments and Hedging Activity	'
	Derivative Instruments and Hedging Activity
	The Company’s use of derivatives consists of an interest rate swap agreement.  The interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to variable, LIBOR-based debt for the duration of the term loan.  The interest rate swap matures in October 2019.  The interest rate swap is considered an effective cash flow hedge, and, as a result, the net gains or losses on such instrument were reported as a component of Other comprehensive income in the condensed consolidated financial statements and are reclassified as net income when the hedge transaction settles.
Revenue Recognition	'
	Revenue Recognition
	The Company recognizes revenue from sales of products upon shipment when title and risk of loss passes, and when terms are fixed and collection is probable. Revenue from services includes after-market services, installation and implementation of products, and turnkey security screening services. The portion of revenue for the sale attributable to installation is deferred and recognized when the installation service is provided. In an instance where terms of sale include subjective customer acceptance criteria, revenue is deferred until the Company has achieved the acceptance criteria. Concurrent with the shipment of the product, the Company accrues estimated product return reserves and warranty expenses. Critical judgments made by management related to revenue recognition include the determination of whether or not customer acceptance criteria are perfunctory or inconsequential. The determination of whether or not customer acceptance terms are perfunctory or inconsequential impacts the amount and timing of revenue recognized. Critical judgments also include estimates of warranty reserves, which are established based on historical experience and knowledge of the product under warranty.
	Revenue from turnkey services agreements is included in revenue from services. In certain agreements, revenue is recognized based upon proportional performance, measured by the actual number of hours incurred divided by the total estimated number of hours for the project. The impact of changes in the estimated hours to service the agreement is reflected in the period during which the change becomes known. Deferred revenue for such agreements arises when payments from customers are received in advance of revenue recognition.
	Revenues from out of warranty service maintenance contracts are recognized ratably over the term of such contract. For services not derived from specific maintenance contracts, revenues are recognized as the services are performed. Deferred revenue for such services arises from payments received from customers for services not yet performed. On occasion, the Company receives advances from customers that are amortized against future customer payments pursuant to the underlying agreements. Such advances are classified in the condensed consolidated balance sheets as either a current or long term liability dependent upon when the Company estimates the corresponding amortization to occur.
Business Combinations	'
	Business Combinations
	During the normal course of business the Company makes acquisitions.  In the event that an individual acquisition (or an aggregate of acquisitions) is material, appropriate disclosure of such acquisition activity is provided.  During the three months ended September 30, 2014, the Company completed an acquisition that was not material.
Recent Accounting Updates Not Yet Adopted	'
	Recent Accounting Updates Not Yet Adopted
	In May 2014, the Financial Accounting Standards Board issued an accounting standards update amending revenue recognition requirements for multiple deliverable revenue arrangements. This update provides guidance on how revenue is recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for the goods or services. This determination is made in five steps: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The update is effective for annual reporting periods after December 15, 2016 and for interim reporting periods within that reporting period. Early adoption is not permitted. The Company has not yet adopted this update and is currently evaluating the impact it may have on its financial condition and results of operations.

Basis_of_Presentation_Tables

Basis of Presentation (Tables)	3 Months Ended
	Sep. 30, 2014
Basis of Presentation	'
Schedule of computation of basic and diluted earnings per share	'
	The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
		Three Months Ended
		September 30,
		2013		2014
	Net income for diluted earnings per share calculation	$	6,394	$	11,249
	Weighted average shares for basic earnings per share calculation	19,971		19,820
	Dilutive effect of stock awards	649		709
	Weighted average shares for diluted earnings per share calculation	20,620		20,529
	Basic net income per share	$	0.32	$	0.57
	Diluted net income per share	$	0.31	$	0.55
Summary of the investments carried at fair value	'
	The following is a summary of the investments carried at fair value (in thousands):
		Level 1		Level 2		June 30,		Level 1		Level 2		September 30,
						2014						2014
	Equity securities	414		500		914		385		1,600		1,985
	Insurance company contracts	—		17,383		17,383		—		18,077		18,077
	Interest rate contract	—		28		28		—		61		61
	Total	$	414	$	17,911	$	18,325	$	385	$	19,738	$	20,123

Balance_Sheet_Details_Tables

Balance Sheet Details (Tables)	3 Months Ended
	Sep. 30, 2014
Balance Sheet Details	'
Schedule of selected balance sheet accounts	'
	The following tables provide details of selected balance sheet accounts (in thousands):
		June 30,			September 30,
		2014			2014
	Accounts receivable
	Billed receivables	$	189,489		$	160,202
	Unbilled receivables	1,975			2,552
	Less allowance for doubtful accounts	(5,691		)	(6,905		)
	Total	$	185,773		$	155,849
		June 30,			September 30,
		2014			2014
	Inventories
	Raw materials	$	117,945		$	146,525
	Work-in-process	33,394			44,743
	Finished goods	82,799			73,126
	Total	$	234,138		$	264,394
		June 30,			September 30,
		2014			2014
	Property and equipment, net
	Land	$	13,651		$	13,651
	Buildings and improvements	163,952			166,468
	Leasehold improvements	9,744			10,058
	Equipment and tooling	154,367			154,501
	Furniture and fixtures	4,017			4,052
	Computer equipment	17,466			17,810
	Computer software	15,670			15,968
	Construction in process	12,650			10,612
	Total	391,517			393,120
	Less: accumulated depreciation and amortization	(131,038		)	(142,927		)
	Property and equipment, net	$	260,479		$	250,193

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets	'
Schedule of carrying amount of goodwill	'
	The changes in the carrying value of goodwill for the three-month period ended September 30, 2014 are as follows (in thousands):
		Security			Healthcare			Optoelectronics			Consolidated
		Division			Division			and
								Manufacturing
								Division
	Balance as of June 30, 2014	$	29,507		$	37,237		$	25,863		$	92,607
	Goodwill acquired or adjusted during the period	19			5,655			37			5,711
	Foreign currency translation adjustment	(281		)	(283		)	(324		)	(888		)
	Balance as of September 30, 2014	$	29,245		$	42,609		$	25,576		$	97,430
Schedule of intangible assets	'
	Intangible assets consisted of the following (in thousands):
				June 30, 2014									September 30, 2014
		Weighted		Gross			Accumulated			Intangibles			Gross		Accumulated		Intangibles
		Average		Carrying			Amortization			Net			Carrying		Amortization		Net
		Lives		Value									Value
	Amortizable assets:
	Software development costs	9 years		$	21,165		6,716			14,449			$	21,275	$	6,855	$	14,420
	Patents	20 years		6,566			765			5,801			6,814		804		6,010
	Core technology	10 years		2,289			2,150			139			2,187		2,109		78
	Developed technology	10 years		18,308			11,559			6,749			20,369		11,853		8,516
	Customer relationships/backlog	7 years		11,419			7,011			4,408			10,070		4,032		6,038
	Total amortizable assets			59,747			28,201			31,546			60,715		25,653		35,062
	Non-amortizable assets:
	Trademarks			12,069			—			12,069			12,566		—		12,566
	Total intangible assets			$	71,816		$	28,201		$	43,615		$	73,281	$	25,653	$	47,628
Schedule of estimated future amortization expense	'
	At September 30, 2014, the estimated future amortization expense was as follows (in thousands):
	Fiscal Years
	2015 (remaining 9 months)	$	2,994
	2016	3,757
	2017	3,913
	2018	3,826
	2019	3,582
	2020	3,116
	2021 and thereafter, including assets that have not yet begun to be amortized	13,874
	Total	$	35,062

Borrowings_Tables

Borrowings (Tables)	3 Months Ended
	Sep. 30, 2014
Borrowings	'
Schedule of long-term debt	'
	Long-term debt consisted of the following (in thousands):
		June 30,		September 30,
		2014		2014
	Term loans	$	10,921	$	11,607
	Other long-term debt	2,334		2,480
		13,255		14,087
	Less current portion of long-term debt	2,819		2,820
	Long-term portion of debt	$	10,436	$	11,267

Stockbased_Compensation_Tables

Stock-based Compensation (Tables)	3 Months Ended
	Sep. 30, 2014
Stock-based Compensation	'
Schedule of stock-based compensation expense recorded in the condensed consolidated statements of operations	'
	The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):
		Three Months Ended
		September 30,
		2013			2014
	Cost of goods sold	$	269		$	205
	Selling, general and administrative	5,303			5,763
	Research and development	66			27
	Stock-based compensation expense before taxes	$	5,638		$	5,995
	Less: related income tax benefit	2,174			2,406
	Stock-based compensation expense, net of estimated taxes	$	3,464		$	3,589
Summary of stock option activity	'
		Number of		Weighted-			Weighted-Average	Aggregate
		Options		Average Exercise			Remaining	Intrinsic Value
				Price			Contractual Term	(in thousands)
	Outstanding at June 30, 2014	1,022,991		$	26.6
	Granted	42,476		$	68.03
	Exercised	(4,154	)	$	50.27
	Expired or forfeited	(2,623	)	$	56.94
	Outstanding at September 30, 2014	1,058,690		$	28.09		5.6 years	$	36,839
	Exercisable at September 30, 2014	949,969		$	24.35		5.2 years	$	36,297
Summary of restricted stock award and RSU award activity	'
		Shares		Weighted-
				Average
				Fair Value
	Nonvested at June 30, 2014	661,400		$	54.78
	Granted	277,536		64.63
	Vested	(233,945	)	42.2
	Forfeited	(6,821	)	37.39
	Nonvested at September 30, 2014	698,170		63.08

Retirement_Benefit_Plans_Table

Retirement Benefit Plans (Tables)	3 Months Ended
	Sep. 30, 2014
Retirement Benefit Plans	'
Schedule of net periodic pension expense	'
	The Company sponsors various retirement benefit plans including qualified and nonqualified defined benefit pension plans for its employees. The components of net periodic pension expense are as follows (in thousands):
		Three Months Ended
		September 30,
		2013		2014
	Service cost	$	293	$	264
	Amortization of prior service cost	202		202
	Net periodic pension expense	$	495	$	466

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	3 Months Ended
	Sep. 30, 2014
Commitments and Contingencies	'
Schedule of changes in warranty provisions	'
	The following table presents changes in warranty provisions (in thousands):
		Three Months Ended
		September 30,
		2013			2014
	Balance at beginning of period	$	12,890		$	11,923
	Additions and adjustments	1,254			847
	Reductions for warranty repair costs	(785		)	(870		)
	Balance at end of period	$	13,359		$	11,900

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Sep. 30, 2014
Segment Information	'
Schedule of operations and identifiable assets by industry segment	'
	The following tables present the operations and identifiable assets by industry segment (in thousands):
		Three Months Ended
		September 30,
		2013			2014
	Revenues(2) — by Segment:
	Security division	$	97,153		$	113,439
	Healthcare division	45,787			47,834
	Optoelectronics and Manufacturing division, including intersegment revenues	71,311			69,086
	Intersegment revenues elimination	(7,977		)	(11,962		)
	Total	$	206,274		$	218,397
		Three Months Ended
		September 30,
		2013			2014
	Operating income (loss) — by Segment:
	Security division	$	11,622		17,259
	Healthcare division	(1,998		)	62
	Optoelectronics and Manufacturing division	4,765			4,327
	Corporate	(4,045		)	(4,517		)
	Eliminations(1)	129			(467		)
	Total	$	10,473		$	16,664
		June 30,			September 30,
		2014			2014
	Assets — by Segment:
	Security division	$	535,306		$	525,293
	Healthcare division	190,612			203,284
	Optoelectronics and Manufacturing division	169,084			165,407
	Corporate	133,836			139,189
	Eliminations(1)	(4,652		)	(5,118		)
	Total	$	1,024,186		$	1,028,055
	(1)    Eliminations within operating income primarily reflect the change in the elimination of intercompany profit in inventory not-yet-realized. Eliminations in assets reflect the amount of intercompany profits in inventory as of the balance sheet date. Such intercompany profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.
	(2)    One customer accounted for 15% of total net revenues for the three months ended September 30, 2013 and 2014.  One customer accounted for 10% of the net receivables as of September 30, 2014.

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
	item
Description of Business	'	'
Number of operating segments	3	'
Earnings per Share	'	'
Antidilutive shares associated with stock awards	100,000	0
Computation of basic and diluted earnings per share	'	'
Net income for diluted earnings per share calculation	$11,249	$6,394
Weighted average shares for basic earnings per share calculation	19,820,000	19,971,000
Dilutive effect of stock awards (in shares)	709,000	649,000
Weighted average shares for diluted earnings per share calculation	20,529,000	20,620,000
Basic net income per share (in dollars per share)	$0.57	$0.32
Diluted net income per share (in dollars per share)	$0.55	$0.31

Basis_of_Presentation_Details_

Basis of Presentation (Details 2) (USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Level 3	'	'
Fair value of financial instruments	'	'
Fair value of assets	$0	$0
Fair value of liabilities	0	0
Recurring | Level 1	'	'
Fair value of financial instruments	'	'
Total	385	414
Recurring | Level 1 | Equity securities	'	'
Fair value of financial instruments	'	'
Equity securities	385	414
Recurring | Level 2	'	'
Fair value of financial instruments	'	'
Insurance company contracts	18,077	17,383
Interest rate contract	61	28
Total	19,738	17,911
Recurring | Level 2 | Equity securities	'	'
Fair value of financial instruments	'	'
Equity securities	1,600	500
Recurring | Total	'	'
Fair value of financial instruments	'	'
Insurance company contracts	18,077	17,383
Interest rate contract	61	28
Total	20,123	18,325
Recurring | Total | Equity securities	'	'
Fair value of financial instruments	'	'
Equity securities	1,985	914
Non-recurring	'	'
Fair value of financial instruments	'	'
Fair value of assets	0	0
Fair value of liabilities	$0	$0

Balance_Sheet_Details_Details

Balance Sheet Details (Details) (USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014
Accounts receivable	'	'	'
Billed receivables	$160,202,000	'	$189,489,000
Unbilled receivables	2,552,000	'	1,975,000
Less allowance for doubtful accounts	-6,905,000	'	-5,691,000
Total	155,849,000	'	185,773,000
Inventories	'	'	'
Raw materials	146,525,000	'	117,945,000
Work-in-process	44,743,000	'	33,394,000
Finished goods	73,126,000	'	82,799,000
Total	264,394,000	'	234,138,000
Property and equipment	'	'	'
Property and equipment, gross	393,120,000	'	391,517,000
Less: accumulated depreciation and amortization	-142,927,000	'	-131,038,000
Property and equipment, net	250,193,000	'	260,479,000
Depreciation expense	16,900,000	11,500,000	'
Land	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	13,651,000	'	13,651,000
Buildings and improvements	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	166,468,000	'	163,952,000
Leasehold improvements	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	10,058,000	'	9,744,000
Equipment and tooling	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	154,501,000	'	154,367,000
Furniture and fixtures	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	4,052,000	'	4,017,000
Computer equipment	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	17,810,000	'	17,466,000
Computer software	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	15,968,000	'	15,670,000
Construction in process	'	'	'
Property and equipment	'	'	'
Property and equipment, gross	$10,612,000	'	$12,650,000

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	$92,607
Goodwill acquired or adjusted during the period	5,711
Foreign currency translation adjustment	-888
Balance at the end of the period	97,430
Security Division	'
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	29,507
Goodwill acquired or adjusted during the period	19
Foreign currency translation adjustment	-281
Balance at the end of the period	29,245
Healthcare Division	'
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	37,237
Goodwill acquired or adjusted during the period	5,655
Foreign currency translation adjustment	-283
Balance at the end of the period	42,609
Optoelectronics and Manufacturing Division	'
Changes in the carrying amount of goodwill	'
Balance at the beginning of the period	25,863
Goodwill acquired or adjusted during the period	37
Foreign currency translation adjustment	-324
Balance at the end of the period	$25,576

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets (Details 2) (USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014
Amortizable assets:	'	'	'
Gross Carrying Value	$60,715,000	'	$59,747,000
Accumulated Amortization	25,653,000	'	28,201,000
Intangibles Net	35,062,000	'	31,546,000
Total intangible assets	'	'	'
Gross Carrying Value	73,281,000	'	71,816,000
Intangibles Net	47,628,000	'	43,615,000
Amortization expense	800,000	1,400,000	'
Estimated future amortization expense	'	'	'
2015 (remaining 9 months)	2,994,000	'	'
2016	3,757,000	'	'
2017	3,913,000	'	'
2018	3,826,000	'	'
2019	3,582,000	'	'
2020	3,116,000	'	'
2021 and thereafter, including assets that have not yet begun to be amortized	13,874,000	'	'
Intangibles Net	35,062,000	'	31,546,000
Trademarks	'	'	'
Non-amortizable assets:	'	'	'
Gross Carrying Value	12,566,000	'	12,069,000
Software development costs	'	'	'
Intangible assets	'	'	'
Weighted Average Lives	'9 years	'	'
Amortizable assets:	'	'	'
Gross Carrying Value	21,275,000	'	21,165,000
Accumulated Amortization	6,855,000	'	6,716,000
Intangibles Net	14,420,000	'	14,449,000
Estimated future amortization expense	'	'	'
Intangibles Net	14,420,000	'	14,449,000
Capitalized software development costs	600,000	1,200,000	'
Patents	'	'	'
Intangible assets	'	'	'
Weighted Average Lives	'20 years	'	'
Amortizable assets:	'	'	'
Gross Carrying Value	6,814,000	'	6,566,000
Accumulated Amortization	804,000	'	765,000
Intangibles Net	6,010,000	'	5,801,000
Estimated future amortization expense	'	'	'
Intangibles Net	6,010,000	'	5,801,000
Core technology	'	'	'
Intangible assets	'	'	'
Weighted Average Lives	'10 years	'	'
Amortizable assets:	'	'	'
Gross Carrying Value	2,187,000	'	2,289,000
Accumulated Amortization	2,109,000	'	2,150,000
Intangibles Net	78,000	'	139,000
Estimated future amortization expense	'	'	'
Intangibles Net	78,000	'	139,000
Developed technology	'	'	'
Intangible assets	'	'	'
Weighted Average Lives	'10 years	'	'
Amortizable assets:	'	'	'
Gross Carrying Value	20,369,000	'	18,308,000
Accumulated Amortization	11,853,000	'	11,559,000
Intangibles Net	8,516,000	'	6,749,000
Estimated future amortization expense	'	'	'
Intangibles Net	8,516,000	'	6,749,000
Customer relationships/backlog	'	'	'
Intangible assets	'	'	'
Weighted Average Lives	'7 years	'	'
Amortizable assets:	'	'	'
Gross Carrying Value	10,070,000	'	11,419,000
Accumulated Amortization	4,032,000	'	7,011,000
Intangibles Net	6,038,000	'	4,408,000
Estimated future amortization expense	'	'	'
Intangibles Net	$6,038,000	'	$4,408,000

Borrowings_Details

Borrowings (Details) (USD $)

Sep. 30, 2014

Jun. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2012

Sep. 30, 2014

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

Revolving credit facility

Bank lines-of-credit

Seven-year term loan due in fiscal 2020

Seven-year term loan due in fiscal 2020

Seven-year term loan due in fiscal 2020

Minimum

Maximum

LIBOR

LIBOR

LIBOR

LIBOR

Minimum

Maximum

Borrowings

'

'

'

'

'

'

'

'

'

'

'

'

Maximum borrowing capacity

'

'

$450,000,000

'

'

'

'

'

'

'

'

'

Sub-limit available for letters of credit

'

'

375,000,000

'

'

'

'

'

'

'

'

'

Increase in the credit agreement's borrowing capacity available under certain circumstances

'

'

200,000,000

'

'

'

'

'

'

'

'

'

Variable basis rate

'

'

'

'

'

'LIBOR

'

'

'

'

'

'LIBOR

Interest rate margin (as a percent)

'

'

'

'

'

1.25%

1.25%

2.00%

'

'

'

1.25%

Unused commitment fee (as a percent)

'

'

0.20%

0.20%

0.35%

'

'

'

'

'

'

'

Amount outstanding

30,000,000

24,000,000

30,000,000

'

'

'

'

'

0

'

'

'

Amount outstanding under lines-of-credit

'

'

100,100,000

'

'

'

'

'

11,600,000

'

'

'

Available credit facility

'

'

'

'

'

'

'

'

26,400,000

'

'

'

Total cash borrowing sub-limit

'

'

'

'

'

'

'

'

2,900,000

'

'

'

Principal amount

'

'

'

'

'

'

'

'

'

'

11,100,000

'

Term of loan

'

'

'

'

'

'

'

'

'

'7 years

'

'

Effective interest rate (as a percent)

'

'

'

'

'

'

'

'

'

2.20%

'

'

Term loans

11,607,000

10,921,000

'

'

'

'

'

'

'

'

'

'

Other long-term debt

2,480,000

2,334,000

'

'

'

'

'

'

'

'

'

'

Long-term debt

14,087,000

13,255,000

'

'

'

'

'

'

'

'

'

'

Less current portion of long-term debt

2,820,000

2,819,000

'

'

'

'

'

'

'

'

'

'

Long-term portion of debt

$11,267,000

$10,436,000

'

'

'

'

'

'

'

'

'

'

Stockbased_Compensation_Detail

Stock-based Compensation (Details) (USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
	item
Stock-based Compensation	'	'
Number of share-based employee compensation plans	2	'
Stock based compensation expense	'	'
Stock-based compensation expense before taxes	$5,995,000	$5,638,000
Less: related income tax benefit	2,406,000	2,174,000
Stock-based compensation expense, net of estimated taxes	3,589,000	3,464,000
Stock Options	'	'
Stock-based compensation, other disclosures	'	'
Unrecognized compensation cost	1,400,000	'
Weighted-average period	'2 years 2 months 12 days	'
Restricted stock and RSU	'	'
Stock-based compensation, other disclosures	'	'
Unrecognized compensation cost	30,500,000	'
Weighted-average period	'1 year 10 months 24 days	'
Cost of goods sold	'	'
Stock based compensation expense	'	'
Stock-based compensation expense before taxes	205,000	269,000
Selling, general and administrative	'	'
Stock based compensation expense	'	'
Stock-based compensation expense before taxes	5,763,000	5,303,000
Research and development	'	'
Stock based compensation expense	'	'
Stock-based compensation expense before taxes	$27,000	$66,000

Stockbased_Compensation_Detail1

Stock-based Compensation (Details 2) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Performance-based restricted stock units	'	'
Shares	'	'
Granted (in shares)	151,469	160,922
Performance-based restricted stock units | Minimum	'	'
Weighted-Average Fair Value	'	'
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the Company's common stock	0.00%	'
Performance-based restricted stock units | Maximum	'	'
Weighted-Average Fair Value	'	'
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the Company's common stock	250.00%	'
OSI Plans | Stock Options	'	'
Number of Options	'	'
Outstanding at the beginning of the period (in shares)	1,022,991	'
Granted (in shares)	42,476	'
Exercised (in shares)	-4,154	'
Expired or forfeited (in shares)	-2,623	'
Outstanding at the end of the period (in shares)	1,058,690	'
Exercisable at the end of the period (in shares)	949,969	'
Weighted-Average Exercise Price	'	'
Outstanding at the beginning of the period (in dollars per share)	26.6	'
Granted (in dollars per share)	68.03	'
Exercised (in dollars per share)	50.27	'
Expired or forfeited (in dollars per share)	56.94	'
Outstanding at the end of the period (in dollars per share)	28.09	'
Exercisable at the end of the period (in dollars per share)	24.35	'
Weighted-Average Remaining Contractual Term	'	'
Outstanding at the end of the period	'5 years 7 months 6 days	'
Exercisable at the end of the period	'5 years 2 months 12 days	'
Aggregate Intrinsic Value	'	'
Outstanding at the end of the period	36,839	'
Exercisable at the end of the period	36,297	'
OSI Plans | Restricted stock and RSU	'	'
Shares	'	'
Nonvested at the beginning of the period (in shares)	661,400	'
Granted (in shares)	277,536	'
Vested (in shares)	-233,945	'
Forfeited (in shares)	-6,821	'
Nonvested at the end of the period (in shares)	698,170	'
Weighted-Average Fair Value	'	'
Nonvested at the beginning of the period (in dollars per share)	54.78	'
Granted (in dollars per share)	64.63	'
Vested (in dollars per share)	42.2	'
Forfeited (in dollars per share)	37.39	'
Nonvested at the end of the period (in dollars per share)	63.08	'
2012 Plan	'	'
Weighted-Average Fair Value	'	'
Securities available for grant	2,973,477	'
2012 Plan | Restricted stock and RSU	'	'
Weighted-Average Fair Value	'	'
Number of shares available for grant reduced for each award granted	1.87	'
Number of shares available for grant increased for each award forfeited and returned	1.87	'

Retirement_Benefit_Plans_Detai

Retirement Benefit Plans (Details) (USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Net Periodic Benefit Costs	'	'
Service costs	$264,000	$293,000
Amortization of prior service costs	202,000	202,000
Net periodic pension expense	466,000	495,000
Contributions made by the entity to the defined benefit plans	1,000,000	100,000
Contributions made by the entity to defined contribution plans	$1,200,000	$1,000,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	1 Months Ended	3 Months Ended						3 Months Ended
	Oct. 31, 2014	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014	Sep. 30, 2014	Jun. 30, 2012	Sep. 30, 2014	Sep. 30, 2014
		item			Mexican government	Mexican government	Maximum	Royalty payments
								item
Contingent Acquisition Obligations	'	'	'	'	'	'	'	'
Maximum amount of future payments under contingent consideration	'	'	'	'	'	'	$58,000,000	'
Purchase agreements containing royalty payments, number	'	'	'	'	'	'	'	1
Fair value of contingent payment obligations	'	24,400,000	'	23,200,000	'	'	'	'
Advances from Customers	'	'	'	'	'	'	'	'
Advances from customers	'	'	'	'	68,800,000	100,000,000	'	'
Environmental Contingencies	'	'	'	'	'	'	'	'
Number of investigations discovering soil and groundwater contamination at Hawthorne, CA facility	'	1	'	'	'	'	'	'
Changes in provision for warranties	'	'	'	'	'	'	'	'
Balance at beginning of period	11,900,000	11,923,000	12,890,000	'	'	'	'	'
Additions and adjustments	'	847,000	1,254,000	'	'	'	'	'
Reductions for warranty repair costs	'	-870,000	-785,000	'	'	'	'	'
Balance at end of period	'	11,900,000	13,359,000	'	'	'	'	'
Other Matters	'	'	'	'	'	'	'	'
Claims by government for compensation due to termination for default	'	$0	'	'	'	'	'	'
Period for which Company's Security division has agreed to extend the term of the Administrative Agreement	'24 months	'	'	'	'	'	'	'

Segment_Information_Details

Segment Information (Details)	3 Months Ended
	Sep. 30, 2014
	item
Segment Information	'
Number of identifiable industry segments	3

Segment_Information_Details_2

Segment Information (Details 2) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014
Operations and identifiable assets by industry segment	'	'	'
Total revenues	$218,397	$206,274	'
Income (loss) from operations	16,664	10,473	'
Segments assets	1,028,055	'	1,024,186
One customer | Revenues | Customer	'	'	'
Operations and identifiable assets by industry segment	'	'	'
Percentage of benchmark derived from specified source	15.00%	15.00%	'
One customer | Accounts receivable | Customer	'	'	'
Operations and identifiable assets by industry segment	'	'	'
Percentage of benchmark derived from specified source	10.00%	'	'
Corporate	'	'	'
Operations and identifiable assets by industry segment	'	'	'
Income (loss) from operations	-4,517	-4,045	'
Segments assets	139,189	'	133,836
Operating Segments | Security Division	'	'	'
Operations and identifiable assets by industry segment	'	'	'
Total revenues	113,439	97,153	'
Income (loss) from operations	17,259	11,622	'
Segments assets	525,293	'	535,306
Operating Segments | Healthcare Division	'	'	'
Operations and identifiable assets by industry segment	'	'	'
Total revenues	47,834	45,787	'
Income (loss) from operations	62	-1,998	'
Segments assets	203,284	'	190,612
Operating Segments | Optoelectronics and Manufacturing Division	'	'	'
Operations and identifiable assets by industry segment	'	'	'
Total revenues	69,086	71,311	'
Income (loss) from operations	4,327	4,765	'
Segments assets	165,407	'	169,084
Eliminations	'	'	'
Operations and identifiable assets by industry segment	'	'	'
Total revenues	-11,962	-7,977	'
Income (loss) from operations	-467	129	'
Segments assets	($5,118)	'	($4,652)